Term |
Definition |
Branched chain amino acids (BCAA) |
The branched-chain amino acids include: leucine (LEU), valine (VAL), isoleucine (ILE) and allo-isoleucine (allo-ILE). They are catabolized by deamination to the branched chain α-keto acids (BCKA) which then become the substrates for branched chain α-ketoacid dehydrogenase |
Branched chain α-ketoacid dehydrogenase (BCKD) |
An enzyme in the pathway for the catabolism of branched chain amino acids. Deleterious mutations in the DNA coding for this enzyme result in the various forms of Maple Syrup Urine Disease or BCKD deficiency |
Thiamin pyrophosphate (TPP) |
A co-factor necessary, along with co-enzyme A and NAD +, for the action of BCKD on the BCKAs. Some milder variant forms of BCKD can be activated by adding thiamin to the treatment protocol |
MS/MS NBS |
Tandem mass spectrometry newborn screening. This technology allows multiple analytes to be identified and quantified in blood spots collected from newborns to screen for multiple genetic disorders |
Intact protein |
Protein as it exists in its natural state in foods |
Parenteral nutrition (TPN) |
The feeding of nutritional products to a person intravenously, bypassing the usual process of eating and digestion. The products are necessarily in a more elemental form, e.g., amino acids instead of intact proteins |
Hemoperfusion |
A method of filtering the blood extracorporeally to remove a toxin or lower the concentration of other substances. As with other extracorporeal methods, such as hemodialysis (HD), hemofiltration (HF) and hemodiafiltration (HDF), the filtered blood is then returned to the body through venous access. |
Modified low-protein foods |
Foods, including pastas and baked goods where higher protein grains/flours are replaced by protein-free starches |
Nutrition care process (NCP) |
A process developed by the Academy of Nutrition and Dietetics to document nutrition problems by defining the PROBLEM, its ETIOLOGY and evidenced by SIGNS and SYMPTOMS |